@article{92d2d0608aba42be92d577b6b9d514ad,
title = "Cyclophilin A is Associated with Peripheral Artery Disease and Chronic Kidney Disease in Geriatrics: The Tianliao Old People (TOP) Study",
abstract = "Cyclophilin A (CyPA), secreted by vascular smooth muscle cells in response to oxidative stress, is important in the pathogenesis of progressive peripheral arterial occlusion disease (PAOD), which is common among chronic kidney disease. We explored the prevalence of PAOD in Taiwan's elderly (≥ 65 years old) population and its association with CyPA and renal function. Residents of Tianliao District, a rural community in southern Taiwan, were surveyed. An ankle-brachial index (ABI) < 0.91 was defined as PAOD. Chronic kidney disease (CKD) was defined based on eGFR levels < 60 mL/min/1.73m 2. Serum CyPA was measured. Of the 473 participants, 68 (14.4%) had PAOD. Multiple logistic regression analysis showed PAOD was significantly associated with lower eGFR, lower BMI, higher glycated hemoglobin and higher pulse pressure. Serum CyPA levels in participants with PAOD were significantly higher than those with normal ABI values (47.3 ± 0.4 vs. 25.5 ± 0.2 ng/mL, p < 0.001). Moreover, eGFR inversely correlated with serum CyPA level (p < 0.05) in participants with CKD, but not in participants with normal renal function. In conclusion, with a prevalence of PAOD as high as 14.4% in an elderly community, CyPA might be the link between PAOD and advanced impaired renal function.",
author = "Liu, {Meng Chuan} and Lee, {Yen Wei} and Lee, {Po Tseng} and Chang, {Chin Sung} and Tai, {Yun Lin} and Yu, {Jia Rong} and Su, {Xiao Ting} and Hsu, {Ling Wei} and Lin, {Sheng Hsiang} and Wu, {Chi Hsing} and Liu, {Ping Yen}",
note = "Funding Information: We thank all the residents of Tianliao and the staffs of Tianliao District Public Health Center for their kind cooperation, and the National Cheng Kung University College of Medicine for its generous support in 2010 and 2012. This research was supported in part by the Headquarters of University Advancement at the National Cheng Kung University; Health Promotion Program: Blood Pressure Control from Health Promotion Administration, Ministry of Health and Welfare, Taiwan, ROC; grants from National Science NSC101-2314-B-006-075-MY2, MOST 103-2628-B-006-002-MY4). We also received grants from National Cheng Kung University Hospital (2012–2015). The investigator (P.Y.L) was granted by {\textquoteleft}{\textquoteleft}A Landmark Project to Promote Innovation & Competitiveness of Clinical Trials by the Excellent Clinical Trial and Research Center in National Cheng Kung University Hospital, Ministry of Health and Welfare, Taiwan.{\textquoteright}{\textquoteright} Publisher Copyright: {\textcopyright} 2015, Macmillan Publishers Limited. All rights reserved.",
year = "2015",
month = apr,
day = "24",
doi = "10.1038/srep09937",
language = "English",
volume = "5",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
}